Cargando…

An RGD-Modified MRI-Visible Polymeric Vector for Targeted siRNA Delivery to Hepatocellular Carcinoma in Nude Mice

RNA interference (RNAi) has significant therapeutic promise for the genetic treatment of hepatocellular carcinoma (HCC). Targeted vectors are able to deliver small interfering RNA (siRNA) into HCC cells with high transfection efficiency and stability. The tripeptide arginine glycine aspartic acid (R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chun, Gong, Faming, Pang, Pengfei, Shen, Min, Zhu, Kangshun, Cheng, Du, Liu, Zhihao, Shan, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676333/ https://www.ncbi.nlm.nih.gov/pubmed/23922634 http://dx.doi.org/10.1371/journal.pone.0066416

Ejemplares similares

An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
por: Shen, Min, et al.
Publicado: (2012)

An MRI-Visible Non-Viral Vector Bearing GD2 Single Chain Antibody for Targeted Gene Delivery to Human Bone Marrow Mesenchymal Stem Cells
por: Pang, Pengfei, et al.
Publicado: (2013)

Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer
por: Chen, Yinting, et al.
Publicado: (2012)

PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells
por: Li, Tianjiao, et al.
Publicado: (2019)

Systemic Administration of siRNA via cRGD-containing Peptide
por: Huang, Yuanyu, et al.
Publicado: (2015)

Protective effect of Gelofusine against cRGD-siRNA-induced nephrotoxicity in mice
por: Liao, Wenjie, et al.
Publicado: (2018)

Enhanced Intercellular Delivery of cRGD–siRNA Conjugates by an Additional Oligospermine Modification
por: Nakamoto, Kosuke, et al.
Publicado: (2018)

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
por: Yu, Xiaolin, et al.
Publicado: (2021)

Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells
por: Zhou, Zhaoxiu, et al.
Publicado: (2017)

Feasibility of cRGD conjugation at 5′-antisense strand of siRNA by phosphodiester linkage extension
por: Zhou, Xinyang, et al.
Publicado: (2021)

Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
por: Chen, Cheng-Wei, et al.
Publicado: (2011)

Multifunctional polymeric micelles for delivery of drugs and siRNA
por: Jhaveri, Aditi M., et al.
Publicado: (2014)

Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA
por: Liu, Xiaoxia, et al.
Publicado: (2014)

Combined Self-Assembled iRGD Polymersomes for Effective Targeted siRNA Anti-Tumor Therapy
por: Li, Dongying, et al.
Publicado: (2022)

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
por: Liu, Qinhua, et al.
Publicado: (2022)

Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice
por: Chen, Jing, et al.
Publicado: (2014)

Inhibition of lung tumor growth in nude mice by siRNA(CD31) targeting PECAM-1
por: OUYANG, JIN-SHENG, et al.
Publicado: (2014)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

The MRI-Visible Nanocomposite Facilitates the Delivery and Tracking of siRNA Loaded DC Vaccine in the Breast Cancer Model
por: Wu, Changqiang, et al.
Publicado: (2021)

Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells
por: Nai, Jingxue, et al.
Publicado: (2021)

cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy
por: Yang, Shuang, et al.
Publicado: (2021)

Local siRNA delivery by non-viral vectors
por: Beilvert, F., et al.
Publicado: (2012)

Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway
por: Cen, Bohong, et al.
Publicado: (2018)

Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
por: Zou, Seyin, et al.
Publicado: (2012)

Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo
por: Lee, Sungmun, et al.
Publicado: (2009)

Polymeric nanoparticles for the delivery of siRNA and the partnership between WSU and UNIT
por: da Rocha, Sandro, et al.
Publicado: (2014)

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng, Yuan, et al.
Publicado: (2018)

Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery
por: Ewe, Alexander, et al.
Publicado: (2019)

Effect of Chitosan Magnetic Nanoparticles Loaded with Ang2-siRNA Plasmids on the Growth of Melanoma Xenografts in Nude Mice
por: Shan, Xiuying, et al.
Publicado: (2020)

Chitosan Hydrogel as siRNA vector for prolonged gene silencing
por: Ma, Zhiwei, et al.
Publicado: (2014)

rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
por: Zheng, Yuanyuan, et al.
Publicado: (2017)

A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo
por: He, Shuai, et al.
Publicado: (2017)

An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo
por: Cen, Bohong, et al.
Publicado: (2018)

Predicting siRNA potency with random forests and support vector machines
por: Wang, Liangjiang, et al.
Publicado: (2010)

Multi-target siRNA: Therapeutic Strategy for Hepatocellular Carcinoma
por: Li, Tiejun, et al.
Publicado: (2016)

Plasma polymerized nanoparticles effectively deliver dual siRNA and drug therapy in vivo
por: Michael, Praveesuda, et al.
Publicado: (2020)

Photocrosslinked Bioreducible Polymeric Nanoparticles for Enhanced Systemic siRNA Delivery as Cancer Therapy
por: Karlsson, Johan, et al.
Publicado: (2021)

Predicting siRNA efficacy based on multiple selective siRNA representations and their combination at score level
por: He, Fei, et al.
Publicado: (2017)

Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
por: Hada, Tomoya, et al.
Publicado: (2015)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
por: Lin, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j8el16g4vj196s77mriunh7ulv